Osteogenex

Small molecule against the validated target Sclerostin to increase bone density

placeOverland Park, Kansas, United States calendar_todayFounded 2006 language osteogenex.com

Innovation

14 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 310 times.

YearFilings
20123
20142

Investor mix

2 investors on record.

Investor typeCountShare
Accelerator & incubator150%
Other / undisclosed150%
Coming soon